22.07.2019 • NewsChemical DistributionOqemaOverlack

Oqema repositions itself in France

The partner companies Oqema and Stockmeier Holding have decided to restructure their holdings in Quaron. Since 2011, Oqema has held 50% of the shares in the jointly acquired Quaron, one of the leading distribution companies for chemicals in France. Quaron was jointly managed by both companies for more than eight years with excellent results. ‘Today, Quaron is about twice as large as when the partnership was formed,’ says Peter Overlack, CEO of Oqema.

The decision to reorganise the French joint venture is not least due to the limited influence of both parent companies on the further development of the joint company.

In addition, Oqema was able to acquire QSO Oqema Whyte, founded in 2003 and based in Vaulx Milieu near Lyon, at the end of 2018. Oqema is thus further expanding its business in France with a focus on specialty chemicals and was able to win Jean Francois Daligault as Managing Director of the branch.

Stockmeier Holding acquires 100% of the shares in Quaron. ‘We are confident that the measure will contribute to a good development for both companies. Peter Overlack had already announced strategic acquisitions at the end of last year. With the name change at the beginning of 2018, the group of companies has set itself the goal of Europe-wide expansion.’

Company

Logo:

OQEMA AG

Schlossstrasse 39
41352 Korschenbroich
Germany

Company contact







CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.